Title: Structural modifications of N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides: influence on lipophilicity and 5-HT7 receptor activity. Part III.
Journal: Journal of medicinal chemistry 20080925
313490-26-5
916488-42-1
80835-30-9
101426-31-7 | 2-(4-Methyl-5-thiazolyl)ethyl decanoate | AA0004DP | MFCD09032915
1015845-66-5 | 1-(1-Methylbutyl)-1h-pyrazol-5-amine | AA0004SP | MFCD08457390
101664-59-9 | 2-Chloro-3,4-dimethoxypyridine | AA00051C | MFCD03411871
1017779-48-4 | 4-Ethoxy-2,6-difluorobenzaldehyde | AA0005EM | MFCD09258695
101870-60-4 | 3-Bromo-2-chloroquinoline | AA0005Q7 | MFCD08457743
10199-69-6 | 1-Methyl-4-phenyl-1H-pyrazole | AA000640 | MFCD12964229
1020252-96-3 | 1-(3-Bromo-5-methylphenylsulfonyl)pyrrolidine | AA0006AU | MFCD09972152
1021019-03-3 | 2-Bromo-[1,2,4]triazolo[1,5-a]pyridine | AA0006K1 | MFCD19441933
102225-88-7 | Benzenemethanol, α-methyl-2,4,6-tris(1-methylethyl)-, (αS)- | AA0006VV | MFCD09836213
1024-99-3 | 5-Iodouridine | AA0007AI | MFCD00006532
